Optimizing antiplatelet and anticoagulant agents in the perioperative orthopedic surgery patient.
Oh
Jennifer J
JJ
University of Kentucky College of Pharmacy, Pharmacy Practice and Science, Lexington, KY 40536, USA.
Robon
Matthew J
MJ
Akers
Wendell S
WS
D000925:Anticoagulants / Q000494:pharmacology / Q000627:therapeutic use*; D005343:Fibrinolytic Agents / Q000494:pharmacology / Q000627:therapeutic use; D000077425:Fondaparinux; D006495:Heparin, Low-Molecular-Weight / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D019637:Orthopedic Procedures; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D011134:Polysaccharides / Q000494:pharmacology / Q000627:therapeutic use; D000078222:Tinzaparin
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight; D010975:Platelet Aggregation Inhibitors; D011134:Polysaccharides; D000078222:Tinzaparin; D000077425:Fondaparinux